Inventor(s): Dr Basil Matta and Dr Frank Rasulo
Member Trust: Cambridge University Hospitals NHS Foundation Trust

Key benefits to technology:

  • HandyTrak™ is a novel stoma creating device for use in the percutaneous tracheostomy field.
  • Has a unique dilation mechanism, giving controlled evenly distributed movement.
  • Prevents tissue damage to the anterior and posterior wall of trachea, hugely reducing trauma.

Technology Summary:

Tracheostomy is one of the most frequently performed surgical procedures on the critically ill patient. The procedure involves making an incision on the anterior aspect of the neck, and opening a direct airway through an incision in the trachea. In the UK an estimated 20,000 tracheostomies are performed each year, with between 120,000 and 165,000 performed in the US. This equates to a market value of around £30million for the UK and US combined.

HandyTrak™ is a new development in the tracheostomy field invented by two Consultant Anaesthetists. The technology uses a novel dilation mechanism that allows for a controlled opening, evenly distributing the force to the tracheal rings and reducing force and contact against the rear wall, potentially reducing the trauma associated with other devices on the market.

HandyTrak™ has been developed as a partnership between the inventors, HEE and JEB Technologies and is in the final development phase, with the ex vivo work complete, the design frozen, tooling underway and the technical file being prepared for CE approval. HandyTrak™ is seeking further investment to support post-CE trials, marketing, sales and distribution over a two-year period.